References
- Zuo TT, Zheng RT, Zeng HM, Zhang SW, Chen WQ. Epidemiology of stomach cancer in China. Chin J Clin Oncol. 2017;44(1):52–58.
- National Clinical Research Center for digestive diseases, Digestive endoscopy branch of Chinese Medical Association, Health Management Branch of Chinese Medical Association, Digestive endoscopy Committee of endoscopists branch of Chinese Medical Association, Digestive endoscopy health management and physical examination committee of endoscopists branch of Chinese Medical Association, National Center for quality control of digestive endoscopy, Cancer endoscopy Committee of China Anti Cancer Association. Expert consensus on early gastric cancer screening process in China (Draft) (Shanghai, 2017). Chin J Gastroenterol. 2018;23(2):92–97. [in Chinese].
- Wu R, Yang C, Ji L, et al. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric. BMC Cancer. 2020;20(1):1110. doi:10.1186/s12885-020-07612-8
- Leung WK, Ho HJ, Lin JT, et al. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study. Gastrointest Endosc. 2018;87(1):119–127.e3. doi:10.1016/j.gie.2017.06.013
- Chen XZ, Huang CZ, Hu WX, et al. Gastric cancer screening by combined determination of serum Helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening. Chin Med J. 2018;131(10):1232–1239. doi:10.4103/0366-6999.231512
- Miftahussurur M, Waskito LA, Aftab H, et al. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One. 2020;15(4):e0230064. doi:10.1371/journal.pone.0230064
- Yu G, Wang GX, Wang HG, et al. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. Neoplasma. 2019;66(04):637–640. doi:10.4149/neo_2018_180825N647
- Tu H, Sun L, Dong X, et al. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Am J Gastroenterol. 2017;112(5):704–715. doi:10.1038/ajg.2017.55
- Huang M, Tang AG, Mu S, et al. Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay. J Clin Pathol. 2014;67(4):350–354. doi:10.1136/jclinpath-2013-201942
- Shafaghi A, Mansour-Ghanaei F, Joukar F, et al. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer Prev. 2013;14(6):3931–3936. doi:10.7314/APJCP.2013.14.6.3931
- CLSI C28-A3. Defining, establishing and verifying reference intervals in the clinical laboratory; proposed guideline-third edition[S]. CLSI; 2008.
- Kim EH, Kang H, Park CH, et al. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis. Dig Liver Dis. 2015;47(8):663–668. doi:10.1016/j.dld.2015.05.014
- Tong Y, Wang H, Zhao Y, et al. Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study. BMC Gastroenterol. 2021;21(1):264. doi:10.1186/s12876-021-01794-6
- Lee SP, Lee SY, Kim JH, et al. Link between serum pepsinogen concentrations and upper gastrointestinal endoscopic findings. J Korean Med Sci. 2017;32(5):796–802. doi:10.3346/jkms.2017.32.5.796
- Yuan L, Zhao JB, Zhou YL, et al. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol. 2020;26(25):3673–3685. doi:10.3748/wjg.v26.i25.3673
- Zhong YM, Liu WE, Li YH, et al. Establishment of serum pepsinogen reference interval for healthy adults in Changsha. Chin J Clin Lab Sci. 2013;31(7):550–551.
- Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54(6):764–768. doi:10.1136/gut.2004.055400
- Miki K, Morita M, Sasajima M, et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol. 2003;98(4):735–739. doi:10.1111/j.1572-0241.2003.07410.x
- Zhong YM, Liu WE, Li YH, et al. Preliminary establishment of serum pepsinogen reference interval in healthy adults in Changsha area. Chinese Journal of Clinical Laboratory Science. 2013;31(7):550–551.